Drugs / BG-C0979
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07414836 | Apr 2026 → Apr 2029 expected | neoplastic disease or syndrome | BeOne Medicines | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BG-C0979 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07414836 ↗ |
| Route | Intravenous | “Administered by intravenous infusion.” NCT07414836 ↗ |